等待開盤 05-05 09:30:00 美东时间
-0.450
-1.64%
Corebridge Financial (NYSE:CRBG) reported quarterly earnings of $1.05 per share which met the analyst consensus estimate. This is a 9.48 percent decrease over earnings of $1.16 per share from the same period last year.
今天 04:29
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
今日重点评级关注:Canaccord Genuity:维持Intellia Therapeutics"买入"评级,目标价从48美元升至58美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从7美元升至8美元
04-29 10:28
UBS analyst Michael Ward maintains Corebridge Financial (NYSE:CRBG) with a Neutral and lowers the price target from $33 to $29.
04-28 22:20
Corebridge Financial, Inc. ("Corebridge" or the "Company") (NYSE:CRBG) today announced the appointment of the Company's Chief Accounting Officer Christopher Filiaggi as Interim Chief Financial Officer, effective April
04-16 04:16
今日重点评级关注:Ascendiant Capital:维持Banzai International"买入"评级,目标价从23美元升至24美元;Ascendiant Capital:维持Synergy CHC Corp."买入"评级,目标价从5美元升至5.5美元
04-15 11:31
今日重点评级关注:HC Wainwright & Co.:维持Solaris Resources"买入"评级,目标价从16美元升至18美元;Leerink Partners:维持Spyre Therapeutics"跑赢大市"评级,目标价从49美元升至106美元
04-14 10:44
今日重点评级关注:Ascendiant Capital:维持Allarity Therapeutics"买入"评级,目标价从9.5美元升至9.75美元;Citizens:维持戴夫"跑赢大市"评级,目标价从310美元升至335美元
04-13 14:07
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5美元升至5.25美元;Benchmark:维持Direct Digital Holdings"投机性买入"评级,目标价从2美元升至8美元
04-09 10:15
Barclays analyst Alex Scott maintains Corebridge Financial (NYSE:CRBG) with a Overweight and lowers the price target from $33 to $30.
04-08 23:24